These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12492446)

  • 21. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteins.
    Escate R; Padro T; Borrell-Pages M; Suades R; Aledo R; Mata P; Badimon L
    J Cell Mol Med; 2017 Mar; 21(3):487-499. PubMed ID: 27680891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.
    Benn M; Watts GF; Tybjærg-Hansen A; Nordestgaard BG
    Eur Heart J; 2016 May; 37(17):1384-94. PubMed ID: 26908947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.
    Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS
    J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two forms of familial hypercholesterolemia: differences in cardiovascular risk factors, cardiac and extracardiac atherosclerosis].
    Vogt A; Keller C; Heigl C; Weiss N; Zöllner N
    Dtsch Med Wochenschr; 2014 Dec; 139(50):2573-7. PubMed ID: 25126774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia.
    Neefjes LA; Ten Kate GJ; Rossi A; Galema-Boers AJ; Langendonk JG; Weustink AC; Moelker A; Nieman K; Mollet NR; Krestin GP; Sijbrands EJ; de Feyter PJ
    Heart; 2011 Jul; 97(14):1151-7. PubMed ID: 21565855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden cardiac death in young adults: environmental risk factors and genetic aspects of premature atherosclerosis.
    Larsen MK; Nissen PH; Kristensen IB; Jensen HK; Banner J
    J Forensic Sci; 2012 May; 57(3):658-62. PubMed ID: 22220933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors.
    Alonso R; Mata N; Castillo S; Fuentes F; Saenz P; Muñiz O; Galiana J; Figueras R; Diaz JL; Gomez-Enterría P; Mauri M; Piedecausa M; Irigoyen L; Aguado R; Mata P;
    Atherosclerosis; 2008 Oct; 200(2):315-21. PubMed ID: 18243212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of plasma lipids, APOE genotype and type of LDL receptor gene mutations on myocardial infarction in subjects with familial hypercholesterolemia].
    Real JT; Ascaso JF; Chaves FJ; González C; Puig O; Armengod ME; Carmena R
    Med Clin (Barc); 2002 May; 118(18):681-5. PubMed ID: 12042130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double heterozygote for familial hypercholesterolaemia and familial defective apolipoprotein B-100.
    Taylor A; Bayly G; Patel K; Yarram L; Williams M; Hamilton-Shield J; Humphries SE; Norbury G
    Ann Clin Biochem; 2010 Sep; 47(Pt 5):487-90. PubMed ID: 20736250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linking genotype to aorto-coronary atherosclerosis: a model using familial hypercholesterolemia and aorto-coronary calcification.
    Jensen JM; Kruse TA; Brorholt-Petersen JU; Christiansen TM; Jensen HK; Kolvraa S; Faergeman O
    Ann Hum Genet; 1999 Nov; 63(Pt 6):511-20. PubMed ID: 11246453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
    Rahman T; Hamzan NS; Mokhsin A; Rahmat R; Ibrahim ZO; Razali R; Thevarajah M; Nawawi H
    Lipids Health Dis; 2017 Apr; 16(1):81. PubMed ID: 28438163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
    Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
    Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC).
    Futema M; Cooper JA; Charakida M; Boustred C; Sattar N; Deanfield J; Lawlor DA; Timpson NJ; ; Humphries SE; Hingorani AD
    Atherosclerosis; 2017 May; 260():47-55. PubMed ID: 28349888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.